Fusion Pharmaceuticals Appoints Mohit Rawat As President And Chief Business Officer
Hamilton, Canada and Boston, USA. 28 September 2021. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the appointment of Mohit Rawat as President and Chief Business Officer. Mr. Rawat brings to Fusion more than 15 years of experience in the biopharmaceutical industry, with expertise […]
Fusion Pharmaceuticals Appoints Mohit Rawat As President And Chief Business Officer Read More »